Morten Persson
Papers
1
Total Citations
56
H-Index
1
About
Morten Persson is a leading figure in molecular imaging and targeted cancer diagnostics, with a primary focus on developing innovative approaches for image-guided surgery in head and neck cancer. His research centers on the urokinase plasminogen activator receptor (uPAR) as a molecular target for both optical near-infrared (NIR) fluorescence imaging and positron emission tomography (PET). Persson’s major contribution lies in demonstrating the feasibility of dual-modality uPAR-targeted imaging, which enables real-time visualization of tumor margins during surgery while also providing preoperative PET-based staging. This proof-of-concept work, published in 2016 and cited over 50 times, established a foundation for improving surgical precision and reducing recurrence rates in head and neck malignancies. His studies, often conducted in orthotopic xenograft models, bridge the gap between preclinical validation and clinical translation. By integrating NIR fluorescence with PET, Persson has advanced the field of theranostics, offering a pathway to personalized surgical interventions. His collaborative work with multidisciplinary teams underscores his impact on translational oncology, making him a key contributor to the future of image-guided cancer care.
Research Focus
Key Achievements
Top Papers
- 1